Establishment Labs
- Country
- Ownership
- -
- Employees
- 908
- Market Cap
- -
- Introduction
Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. It generates income from customers in Europe, the Middle East, Latin America, and Asia. The firm's products include Motiva Implants, Motiva Flora Tissue Expander, Motiva Ergonomix, and Motiva Ergonomix2. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Alajuela, Costa Rica.
Clinical Trials
7
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Adaptive Study to Assess the Safety and Functioning of Motiva Devices on Minimally Invasive Gluteal Augmentation
- Conditions
- Device Safety
- First Posted Date
- 2025-08-21
- Last Posted Date
- 2025-08-21
- Lead Sponsor
- Establishment Labs
- Target Recruit Count
- 120
- Registration Number
- NCT07135011
- Locations
- 🇨🇷
Establishment Labs, Alajuela, San José, Costa Rica
Mia® Clinical Study
- Conditions
- Breast Augmentation
- First Posted Date
- 2025-01-24
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Establishment Labs
- Target Recruit Count
- 100
- Registration Number
- NCT06792409
- Locations
- 🇨🇷
Centro Europeo de Cirugía, San José, Costa Rica
Safety and Performance of Motiva® Sizers
- Conditions
- Breast AugmentationBreast Implantation; Methods, Safety and PerformanceMammaplastyBreast ReconstructionBreast Implant; Complications
- First Posted Date
- 2024-02-23
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Establishment Labs
- Target Recruit Count
- 330
- Registration Number
- NCT06274736
- Locations
- 🇨🇷
Establishment Labs, Coyol, Alajuela, Costa Rica
Motiva Flora® Aesthetic Breast Recon® Clinical Study
- Conditions
- Breast CancerMammaplastyPoland Syndrome
- First Posted Date
- 2023-11-24
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- Establishment Labs
- Target Recruit Count
- 66
- Registration Number
- NCT06146231
- Locations
- 🇧🇪
Universitair Ziekenhuis Gent, Ghent, Belgium
🇨🇴Hospital Universitario San Ignacio, Bogotá, Colombia
🇨🇷Hospital UNIBE, San José, Costa Rica
Retrospective Data Collection on the Use of Motiva Flora TE in Breast Reconstruction
- Conditions
- Breast Cancer
- First Posted Date
- 2022-07-14
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- Establishment Labs
- Target Recruit Count
- 144
- Registration Number
- NCT05459064
- Locations
- 🇧🇪
Dr Filip Stillaert, Ghent, Belgium
🇪🇸Fundacion Tejerina, Madrid, Spain
- Prev
- 1
- 2
- Next
News
Establishment Labs Gains FDA Approval for Motiva Breast Implants
Establishment Labs has received FDA approval for its Motiva SmoothSilk Ergonomix and Round breast implants for primary and revision augmentation.